Allstate Corporation’s Organon & Co OGN Stock Holding History

Allstate Corporation’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$661K	Buy	48,790 +1,167	+2%	+$14K	0.01%	920
2026 Q1	$285K	Buy	+47,623	New	+$358K	﹤0.01%	1082

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Allstate Corporation's OGN Position: Q2 2026 in Review

Allstate Corporation increased its Organon & Co (OGN) stake by 2.5% in Q2 2026, buying an estimated $14K and bringing the position to 48,790 shares worth $661K. The position accounts for 0.01% of the portfolio, ranked #920.

Allstate Corporation first reported a position in OGN in Q1 2026 and has held it in 2 quarters since. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Allstate Corporation held 48,790 shares of Organon & Co worth $661K as of Q2 2026.
Allstate Corporation bought 1,167 Organon & Co shares in Q2 2026, an estimated $14K.
Organon & Co made up 0.01% of Allstate Corporation's portfolio in Q2 2026, its #920 holding.
Allstate Corporation first reported a position in Organon & Co in Q1 2026 and has held it in 2 quarters since.
627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.